Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Biomed Pharmacother. 2021 May 25;140:111753. doi: 10.1016/j.biopha.2021.111753

Table 1.

Selected lncRNAs involved in stroke pathogenesis.

LncRNA Target (s) Effect (s) Study models Ref
N1LR Maybe inactivates p53 Inhibits neural death and apoptosis probably via reducing p53 phosphorylation In vitro: N2a cells In vivo: SD rats, mice [76]
MALAT1 E-selectin and Bim Inhibits inflammation and endothelial cell death and defends cerebral parenchyma and microvasculature from brain ischemic injury. In vitro: BMECs In vivo: C57BL/6 mice [83]
H19 DUSP5-ERK1/2 Silenced autophagy which activated by OGD/R via DUSP5-ERK1/2 axis. In vitro: SH-SY5Y cells In vivo: SD rats [84]
TUG1 miR-9/Bcl2l11 Inhibits miR-9 and weakened suppression of bcl2l11 expression and so, leads a neurotoxicity after stroke. In vitro: SH-SY5Y cells In vivo: SD rats [85]
C2dat1 CaMKIIδ Increases the CaMKIIδ expression and activates NF-κB signal impacting neuronal survival after ischemic stroke. n vitro: N2a cells In vivo: C57BL/6 mice [86]
ANRIL VEGF/NF-κB Increases VEGF expression and activates angiogenesis via activation of NF-κB pathway In vivo: male Wistar rats [87]